glp-1 telehealth crackdown news today Last month, the FDA issued 25 warning letters to companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below Legal fights brewing over the

In these studies, participants taking Mounjaro experienced average weight losses of 15% to over 20% of their body weight at higher doses, with the majority of this weight loss coming from fat

Serious side effects could occur in rare cases, including pancreatitis or gallbladder problems

Injectable forms remain the most effective and reliable delivery method

Sergey Terushkin, MD, FACS As a bariatric surgeon and weight-loss specialist, Ive watched the evolution of obesity treatment for over a decade

Matching Medications to Individual Needs Not every medication fits every patient, and the program is designed with this in mind

Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH